Focus Partners Wealth raised its stake in Relx Plc (NYSE:RELX - Free Report) by 84.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,235 shares of the technology company's stock after acquiring an additional 4,701 shares during the quarter. Focus Partners Wealth's holdings in Relx were worth $471,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. LGT Group Foundation purchased a new stake in shares of Relx during the 4th quarter valued at approximately $257,000. Paradigm Asset Management Co. LLC lifted its stake in shares of Relx by 17.1% during the 4th quarter. Paradigm Asset Management Co. LLC now owns 81,600 shares of the technology company's stock valued at $3,706,000 after buying an additional 11,900 shares in the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of Relx by 120.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 12,066 shares of the technology company's stock valued at $548,000 after buying an additional 6,588 shares in the last quarter. Merit Financial Group LLC purchased a new stake in shares of Relx during the 4th quarter valued at approximately $301,000. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Relx by 19.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 143,483 shares of the technology company's stock valued at $6,517,000 after buying an additional 23,183 shares in the last quarter. 15.02% of the stock is currently owned by hedge funds and other institutional investors.
Relx Price Performance
Relx stock traded up $0.47 during midday trading on Friday, reaching $55.45. 873,655 shares of the stock were exchanged, compared to its average volume of 709,249. The company's fifty day moving average is $51.79 and its 200-day moving average is $49.17. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The firm has a market cap of $102.36 billion, a PE ratio of 29.81, a PEG ratio of 2.73 and a beta of 0.86. Relx Plc has a 52 week low of $43.28 and a 52 week high of $55.68.
Wall Street Analyst Weigh In
A number of analysts recently commented on RELX shares. Morgan Stanley restated an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. The Goldman Sachs Group began coverage on shares of Relx in a research note on Wednesday, March 26th. They set a "buy" rating on the stock. Barclays raised shares of Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Finally, Wall Street Zen lowered shares of Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Buy".
Read Our Latest Research Report on Relx
About Relx
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Articles

Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.